Effectiveness of Tranexamic Acid to Prevent Blood Loss in Patients Undergoing Hip Arthroplasty: A Randomised Controlled Study

Introduction: The safe and efficient Intravenous (i.v.) administration of Tranexamic Acid (TXA) has been shown to reduce blood loss and transfusion requirements following total hip replacement. However, its effectiveness in hip arthroplasty for femoral neck fractures remains a subject of debate to date. Aim: To evaluate the effects of TXA in patients undergoing hip arthroplasty to prevent blood loss. Materials and Methods: The present prospective, doubleblinded, randomised controlled study was conducted in in the Department of Orthopaedics, SRM Medical College Hospital and Research Institute (a tertiary care facility), Chengalpattu, Tamil Nadu, India, between August 2023 and January 2024. Study involved 138 participants with hip fractures classified into a TXA group (group A) and a placebo group (group B). The selected participants were monitored for blood loss, haemoglobin levels and blood transfusion volume. Statistical analysis was performed using Statistical Package for Social Sciences (SPSS) software version 21.0, with t-tests and chisquare tests employed to compare participant characteristics. Results: In the present study, 69 of the 138 individuals received TXA in the interventional group, while 69 received a placebo in the control group. The mean±Standard Deviation (SD) age was 44.6±17.6 years in the interventional group and 48.5±16.4 years in the control group. Postoperatively, the interventional group exhibited a smaller decline in haemoglobin levels (12 g/dL vs. 11.0 g/dL). TXA significantly reduced transfusion volume (p-value <0.001). Additionally, blood loss was lower in patients receiving TXA (p-value <0.001). Conclusion: Treatment for hip fractures with TXA showed a tendency towards reduced blood loss and transfusions, as well as, a shortened total duration of surgery among the study participants. This indicates that TXA is safe and efficient in minimising blood loss during surgery.

Authors

Publication Details

Journal
JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH
Published
2025-02-01
DOI
https://doi.org/10.7860/jcdr/2025/76185.20675
Primary Topic
Blood transfusion and management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Effectiveness of Tranexamic Acid to Prevent Blood Loss in Patients Undergoing Hip Arthroplasty: A Randomised Controlled Study

Sabari Vaasan Lakshmi Kanthan, Aravindhan Krishnasamy Yuvaraj, Ashwin Ravichandran, Tathagath Tiwary et al.
JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH
Blood transfusion and management
article

Effectiveness of Tranexamic Acid to Prevent Blood Loss in Patients Undergoing Hip Arthroplasty: A Randomised Controlled Study

Sabari Vaasan Lakshmi Kanthan, Aravindhan Krishnasamy Yuvaraj, Ashwin Ravichandran, Tathagath Tiwary, Raju Marisiddaiah, Gowthaman Nambiraj, Saravanan Ravi, Rajavel Kalirajan
article en

Abstract

Introduction: The safe and efficient Intravenous (i.v.) administration of Tranexamic Acid (TXA) has been shown to reduce blood loss and transfusion requirements following total hip replacement. However, its effectiveness in hip arthroplasty for femoral neck fractures remains a subject of debate to date. Aim: To evaluate the effects of TXA in patients undergoing hip arthroplasty to prevent blood loss. Materials and Methods: The present prospective, doubleblinded, randomised controlled study was conducted in in the Department of Orthopaedics, SRM Medical College Hospital and Research Institute (a tertiary care facility), Chengalpattu, Tamil Nadu, India, between August 2023 and January 2024. Study involved 138 participants with hip fractures classified into a TXA group (group A) and a placebo group (group B). The selected participants were monitored for blood loss, haemoglobin levels and blood transfusion volume. Statistical analysis was performed using Statistical Package for Social Sciences (SPSS) software version 21.0, with t-tests and chisquare tests employed to compare participant characteristics. Results: In the present study, 69 of the 138 individuals received TXA in the interventional group, while 69 received a placebo in the control group. The mean±Standard Deviation (SD) age was 44.6±17.6 years in the interventional group and 48.5±16.4 years in the control group. Postoperatively, the interventional group exhibited a smaller decline in haemoglobin levels (12 g/dL vs. 11.0 g/dL). TXA significantly reduced transfusion volume (p-value <0.001). Additionally, blood loss was lower in patients receiving TXA (p-value <0.001). Conclusion: Treatment for hip fractures with TXA showed a tendency towards reduced blood loss and transfusions, as well as, a shortened total duration of surgery among the study participants. This indicates that TXA is safe and efficient in minimising blood loss during surgery.

JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH
Openalex Percentile: Top 97%
Blood transfusion and management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Effectiveness of Tranexamic Acid to Prevent Blood Loss in Patients Undergoing Hip Arthroplasty: A Randomised Controlled Study — Sabari Vaasan Lakshmi Kanthan, Aravindhan Krishnasamy Yuvaraj, et al. · JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH (2025) | TGRS Research Map | TGRS